| GO:0046637 | regulation of alpha-beta T cell differentiation | 100.0% (2/2) | 10.8 | 0.0 | 1.1e-05 |
| GO:0046638 | positive regulation of alpha-beta T cell differentiation | 100.0% (2/2) | 10.8 | 0.0 | 1.1e-05 |
| GO:0010929 | positive regulation of auxin mediated signaling pathway | 100.0% (2/2) | 10.5 | 0.0 | 1.2e-05 |
| GO:0048538 | thymus development | 100.0% (2/2) | 10.5 | 0.0 | 1.2e-05 |
| GO:0045621 | positive regulation of lymphocyte differentiation | 100.0% (2/2) | 10.35 | 1e-06 | 1.2e-05 |
| GO:0046634 | regulation of alpha-beta T cell activation | 100.0% (2/2) | 10.35 | 1e-06 | 1.2e-05 |
| GO:0046635 | positive regulation of alpha-beta T cell activation | 100.0% (2/2) | 10.35 | 1e-06 | 1.2e-05 |
| GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation | 100.0% (2/2) | 10.86 | 0.0 | 1.2e-05 |
| GO:0034587 | piRNA metabolic process | 100.0% (2/2) | 10.45 | 0.0 | 1.2e-05 |
| GO:1990511 | piRNA biosynthetic process | 100.0% (2/2) | 10.93 | 0.0 | 1.2e-05 |
| GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 100.0% (2/2) | 11.01 | 0.0 | 1.2e-05 |
| GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 100.0% (2/2) | 11.01 | 0.0 | 1.2e-05 |
| GO:0045622 | regulation of T-helper cell differentiation | 100.0% (2/2) | 11.01 | 0.0 | 1.2e-05 |
| GO:0045624 | positive regulation of T-helper cell differentiation | 100.0% (2/2) | 11.01 | 0.0 | 1.2e-05 |
| GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 100.0% (2/2) | 11.01 | 0.0 | 1.2e-05 |
| GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation | 100.0% (2/2) | 11.01 | 0.0 | 1.2e-05 |
| GO:0045582 | positive regulation of T cell differentiation | 100.0% (2/2) | 10.55 | 0.0 | 1.2e-05 |
| GO:0048536 | spleen development | 100.0% (2/2) | 10.55 | 0.0 | 1.2e-05 |
| GO:0045580 | regulation of T cell differentiation | 100.0% (2/2) | 10.25 | 1e-06 | 1.3e-05 |
| GO:0048566 | embryonic digestive tract development | 100.0% (2/2) | 10.61 | 0.0 | 1.3e-05 |
| GO:0070741 | response to interleukin-6 | 100.0% (2/2) | 10.17 | 1e-06 | 1.3e-05 |
| GO:0071354 | cellular response to interleukin-6 | 100.0% (2/2) | 10.17 | 1e-06 | 1.3e-05 |
| GO:0007141 | male meiosis I | 100.0% (2/2) | 10.08 | 1e-06 | 1.4e-05 |
| GO:0045619 | regulation of lymphocyte differentiation | 100.0% (2/2) | 9.9 | 1e-06 | 1.5e-05 |
| GO:0048565 | digestive tract development | 100.0% (2/2) | 9.9 | 1e-06 | 1.5e-05 |
| GO:1901347 | negative regulation of secondary cell wall biogenesis | 100.0% (2/2) | 11.8 | 0.0 | 1.5e-05 |
| GO:1903339 | negative regulation of cell wall organization or biogenesis | 100.0% (2/2) | 11.8 | 0.0 | 1.5e-05 |
| GO:1901348 | positive regulation of secondary cell wall biogenesis | 100.0% (2/2) | 9.8 | 1e-06 | 1.6e-05 |
| GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 100.0% (2/2) | 9.8 | 1e-06 | 1.6e-05 |
| GO:1903340 | positive regulation of cell wall organization or biogenesis | 100.0% (2/2) | 9.8 | 1e-06 | 1.6e-05 |
| GO:1902107 | positive regulation of leukocyte differentiation | 100.0% (2/2) | 9.93 | 1e-06 | 1.6e-05 |
| GO:1903708 | positive regulation of hemopoiesis | 100.0% (2/2) | 9.93 | 1e-06 | 1.6e-05 |
| GO:0043525 | positive regulation of neuron apoptotic process | 100.0% (2/2) | 9.97 | 1e-06 | 1.6e-05 |
| GO:0030183 | B cell differentiation | 100.0% (2/2) | 9.83 | 1e-06 | 1.6e-05 |
| GO:0050870 | positive regulation of T cell activation | 100.0% (2/2) | 9.7 | 1e-06 | 1.7e-05 |
| GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 100.0% (2/2) | 9.7 | 1e-06 | 1.7e-05 |
| GO:0051571 | positive regulation of histone H3-K4 methylation | 100.0% (2/2) | 9.67 | 1e-06 | 1.7e-05 |
| GO:0022409 | positive regulation of cell-cell adhesion | 100.0% (2/2) | 9.61 | 2e-06 | 1.8e-05 |
| GO:1903037 | regulation of leukocyte cell-cell adhesion | 100.0% (2/2) | 9.55 | 2e-06 | 1.9e-05 |
| GO:0010529 | negative regulation of transposition | 100.0% (2/2) | 9.47 | 2e-06 | 2.1e-05 |
| GO:0071987 | WD40-repeat domain binding | 100.0% (2/2) | 9.45 | 2e-06 | 2.1e-05 |
| GO:0050863 | regulation of T cell activation | 100.0% (2/2) | 9.42 | 2e-06 | 2.1e-05 |
| GO:0007127 | meiosis I | 100.0% (2/2) | 9.37 | 2e-06 | 2.2e-05 |
| GO:1902105 | regulation of leukocyte differentiation | 100.0% (2/2) | 9.35 | 2e-06 | 2.3e-05 |
| GO:1901216 | positive regulation of neuron death | 100.0% (2/2) | 9.32 | 2e-06 | 2.3e-05 |
| GO:0042113 | B cell activation | 100.0% (2/2) | 9.28 | 3e-06 | 2.4e-05 |
| GO:0017145 | stem cell division | 100.0% (2/2) | 9.25 | 3e-06 | 2.4e-05 |
| GO:0000082 | G1/S transition of mitotic cell cycle | 100.0% (2/2) | 9.21 | 3e-06 | 2.5e-05 |
| GO:0010528 | regulation of transposition | 100.0% (2/2) | 9.21 | 3e-06 | 2.5e-05 |
| GO:0010199 | organ boundary specification between lateral organs and the meristem | 100.0% (2/2) | 9.19 | 3e-06 | 2.5e-05 |
| GO:0051574 | positive regulation of histone H3-K9 methylation | 100.0% (2/2) | 9.13 | 3e-06 | 2.7e-05 |
| GO:0044843 | cell cycle G1/S phase transition | 100.0% (2/2) | 9.1 | 3e-06 | 2.7e-05 |
| GO:0051251 | positive regulation of lymphocyte activation | 100.0% (2/2) | 8.93 | 4e-06 | 3.3e-05 |
| GO:0051569 | regulation of histone H3-K4 methylation | 100.0% (2/2) | 8.91 | 4e-06 | 3.4e-05 |
| GO:0022407 | regulation of cell-cell adhesion | 100.0% (2/2) | 8.86 | 5e-06 | 3.6e-05 |
| GO:0002696 | positive regulation of leukocyte activation | 100.0% (2/2) | 8.81 | 5e-06 | 3.7e-05 |
| GO:1990823 | response to leukemia inhibitory factor | 100.0% (2/2) | 8.75 | 5e-06 | 3.8e-05 |
| GO:1990830 | cellular response to leukemia inhibitory factor | 100.0% (2/2) | 8.75 | 5e-06 | 3.8e-05 |
| GO:0007140 | male meiotic nuclear division | 100.0% (2/2) | 8.7 | 6e-06 | 3.8e-05 |
| GO:0050867 | positive regulation of cell activation | 100.0% (2/2) | 8.7 | 6e-06 | 3.8e-05 |
| GO:0048568 | embryonic organ development | 100.0% (2/2) | 8.73 | 5e-06 | 3.8e-05 |
| GO:0051249 | regulation of lymphocyte activation | 100.0% (2/2) | 8.68 | 6e-06 | 3.8e-05 |
| GO:0030098 | lymphocyte differentiation | 100.0% (2/2) | 8.78 | 5e-06 | 3.8e-05 |
| GO:0051570 | regulation of histone H3-K9 methylation | 100.0% (2/2) | 8.72 | 6e-06 | 3.9e-05 |
| GO:0045785 | positive regulation of cell adhesion | 100.0% (2/2) | 8.76 | 5e-06 | 3.9e-05 |
| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | 100.0% (2/2) | 8.63 | 6e-06 | 4.1e-05 |
| GO:0016363 | nuclear matrix | 100.0% (2/2) | 8.61 | 6e-06 | 4.1e-05 |
| GO:1903131 | mononuclear cell differentiation | 100.0% (2/2) | 8.6 | 7e-06 | 4.2e-05 |
| GO:0061982 | meiosis I cell cycle process | 100.0% (2/2) | 8.45 | 8e-06 | 5e-05 |
| GO:0002699 | positive regulation of immune effector process | 100.0% (2/2) | 8.42 | 8e-06 | 5.1e-05 |
| GO:0048872 | homeostasis of number of cells | 100.0% (2/2) | 8.42 | 8e-06 | 5.1e-05 |
| GO:0001701 | in utero embryonic development | 100.0% (2/2) | 8.4 | 9e-06 | 5.2e-05 |
| GO:0002694 | regulation of leukocyte activation | 100.0% (2/2) | 8.36 | 9e-06 | 5.2e-05 |
| GO:0043523 | regulation of neuron apoptotic process | 100.0% (2/2) | 8.36 | 9e-06 | 5.2e-05 |
| GO:0030099 | myeloid cell differentiation | 100.0% (2/2) | 8.34 | 1e-05 | 5.3e-05 |
| GO:0090691 | formation of plant organ boundary | 100.0% (2/2) | 8.34 | 1e-05 | 5.3e-05 |
| GO:1901001 | negative regulation of response to salt stress | 100.0% (2/2) | 8.37 | 9e-06 | 5.3e-05 |
| GO:0002521 | leukocyte differentiation | 100.0% (2/2) | 8.3 | 1e-05 | 5.4e-05 |
| GO:0048859 | formation of anatomical boundary | 100.0% (2/2) | 8.3 | 1e-05 | 5.4e-05 |
| GO:0002697 | regulation of immune effector process | 100.0% (2/2) | 8.28 | 1e-05 | 5.5e-05 |
| GO:0050865 | regulation of cell activation | 100.0% (2/2) | 8.25 | 1.1e-05 | 5.6e-05 |
| GO:0046649 | lymphocyte activation | 100.0% (2/2) | 8.23 | 1.1e-05 | 5.7e-05 |
| GO:1903706 | regulation of hemopoiesis | 100.0% (2/2) | 8.23 | 1.1e-05 | 5.7e-05 |
| GO:0031062 | positive regulation of histone methylation | 100.0% (2/2) | 8.17 | 1.2e-05 | 6.1e-05 |
| GO:0044772 | mitotic cell cycle phase transition | 100.0% (2/2) | 8.16 | 1.2e-05 | 6.1e-05 |
| GO:0140013 | meiotic nuclear division | 100.0% (2/2) | 8.08 | 1.3e-05 | 6.7e-05 |
| GO:0048534 | hematopoietic or lymphoid organ development | 100.0% (2/2) | 8.04 | 1.4e-05 | 7e-05 |
| GO:0045321 | leukocyte activation | 100.0% (2/2) | 8.02 | 1.5e-05 | 7.2e-05 |
| GO:0044770 | cell cycle phase transition | 100.0% (2/2) | 8.01 | 1.5e-05 | 7.2e-05 |
| GO:2000031 | regulation of salicylic acid mediated signaling pathway | 100.0% (2/2) | 7.95 | 1.6e-05 | 7.7e-05 |
| GO:0035295 | tube development | 100.0% (2/2) | 7.91 | 1.7e-05 | 8e-05 |
| GO:0001775 | cell activation | 100.0% (2/2) | 7.9 | 1.7e-05 | 8.1e-05 |
| GO:0006816 | calcium ion transport | 100.0% (2/2) | 7.9 | 1.7e-05 | 8.1e-05 |
| GO:0001216 | DNA-binding transcription activator activity | 100.0% (2/2) | 7.86 | 1.8e-05 | 8.4e-05 |
| GO:0030155 | regulation of cell adhesion | 100.0% (2/2) | 7.81 | 2e-05 | 8.9e-05 |
| GO:1902074 | response to salt | 100.0% (2/2) | 7.78 | 2.1e-05 | 9.2e-05 |
| GO:1901214 | regulation of neuron death | 100.0% (2/2) | 7.75 | 2.2e-05 | 9.5e-05 |
| GO:0000280 | nuclear division | 100.0% (2/2) | 7.72 | 2.2e-05 | 9.7e-05 |
| GO:2000652 | regulation of secondary cell wall biogenesis | 100.0% (2/2) | 7.7 | 2.3e-05 | 9.9e-05 |
| GO:0031058 | positive regulation of histone modification | 100.0% (2/2) | 7.69 | 2.3e-05 | 0.0001 |
| GO:0010928 | regulation of auxin mediated signaling pathway | 100.0% (2/2) | 7.65 | 2.5e-05 | 0.000104 |
| GO:0043009 | chordate embryonic development | 100.0% (2/2) | 7.64 | 2.5e-05 | 0.000105 |
| GO:0048732 | gland development | 100.0% (2/2) | 7.6 | 2.7e-05 | 0.00011 |
| GO:0043065 | positive regulation of apoptotic process | 100.0% (2/2) | 7.49 | 3.1e-05 | 0.000127 |
| GO:2000022 | regulation of jasmonic acid mediated signaling pathway | 100.0% (2/2) | 7.46 | 3.2e-05 | 0.000131 |
| GO:0007283 | spermatogenesis | 100.0% (2/2) | 7.45 | 3.3e-05 | 0.000132 |
| GO:0031060 | regulation of histone methylation | 100.0% (2/2) | 7.4 | 3.5e-05 | 0.000139 |
| GO:0048285 | organelle fission | 100.0% (2/2) | 7.31 | 4e-05 | 0.000156 |
| GO:1903338 | regulation of cell wall organization or biogenesis | 100.0% (2/2) | 7.31 | 3.9e-05 | 0.000156 |
| GO:0048232 | male gamete generation | 100.0% (2/2) | 7.25 | 4.3e-05 | 0.000166 |
| GO:0071345 | cellular response to cytokine stimulus | 100.0% (2/2) | 7.18 | 4.8e-05 | 0.000183 |
| GO:0045596 | negative regulation of cell differentiation | 100.0% (2/2) | 7.15 | 5e-05 | 0.00019 |
| GO:0044089 | positive regulation of cellular component biogenesis | 100.0% (2/2) | 7.07 | 5.5e-05 | 0.000209 |
| GO:0009792 | embryo development ending in birth or egg hatching | 100.0% (2/2) | 6.95 | 6.5e-05 | 0.000245 |
| GO:0031056 | regulation of histone modification | 100.0% (2/2) | 6.86 | 7.4e-05 | 0.000276 |
| GO:1900150 | regulation of defense response to fungus | 100.0% (2/2) | 6.82 | 7.8e-05 | 0.000283 |
| GO:0048527 | lateral root development | 100.0% (2/2) | 6.82 | 7.8e-05 | 0.000284 |
| GO:0006338 | chromatin remodeling | 100.0% (2/2) | 6.83 | 7.7e-05 | 0.000285 |
| GO:0034097 | response to cytokine | 100.0% (2/2) | 6.81 | 7.9e-05 | 0.000286 |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 100.0% (2/2) | 6.79 | 8.1e-05 | 0.00029 |
| GO:0048528 | post-embryonic root development | 100.0% (2/2) | 6.73 | 8.9e-05 | 0.000314 |
| GO:1901000 | regulation of response to salt stress | 100.0% (2/2) | 6.7 | 9.2e-05 | 0.000322 |
| GO:0007276 | gamete generation | 100.0% (2/2) | 6.65 | 9.9e-05 | 0.000343 |
| GO:0090696 | post-embryonic plant organ development | 100.0% (2/2) | 6.65 | 9.9e-05 | 0.000344 |
| GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 100.0% (2/2) | 6.62 | 0.000103 | 0.000354 |
| GO:0045597 | positive regulation of cell differentiation | 100.0% (2/2) | 6.55 | 0.000114 | 0.000388 |
| GO:0000122 | negative regulation of transcription by RNA polymerase II | 100.0% (2/2) | 6.46 | 0.000128 | 0.000432 |
| GO:0006325 | chromatin organization | 100.0% (2/2) | 6.45 | 0.00013 | 0.000434 |
| GO:0043068 | positive regulation of programmed cell death | 100.0% (2/2) | 6.42 | 0.000135 | 0.000445 |
| GO:0047484 | regulation of response to osmotic stress | 100.0% (2/2) | 6.42 | 0.000135 | 0.000445 |
| GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 100.0% (2/2) | 6.41 | 0.000139 | 0.000453 |
| GO:0008284 | positive regulation of cell population proliferation | 100.0% (2/2) | 6.32 | 0.000157 | 0.000509 |
| GO:0016143 | S-glycoside metabolic process | 100.0% (2/2) | 6.27 | 0.000167 | 0.000528 |
| GO:0019757 | glycosinolate metabolic process | 100.0% (2/2) | 6.27 | 0.000167 | 0.000528 |
| GO:0019760 | glucosinolate metabolic process | 100.0% (2/2) | 6.27 | 0.000167 | 0.000528 |
| GO:0000987 | cis-regulatory region sequence-specific DNA binding | 100.0% (2/2) | 6.2 | 0.000186 | 0.000584 |
| GO:0010942 | positive regulation of cell death | 100.0% (2/2) | 6.19 | 0.000188 | 0.000589 |
| GO:0071634 | regulation of transforming growth factor beta production | 50.0% (1/2) | 12.25 | 0.000205 | 0.000613 |
| GO:0071636 | positive regulation of transforming growth factor beta production | 50.0% (1/2) | 12.25 | 0.000205 | 0.000613 |
| GO:1904897 | regulation of hepatic stellate cell proliferation | 50.0% (1/2) | 12.25 | 0.000205 | 0.000613 |
| GO:1904899 | positive regulation of hepatic stellate cell proliferation | 50.0% (1/2) | 12.25 | 0.000205 | 0.000613 |
| GO:2000843 | regulation of testosterone secretion | 50.0% (1/2) | 12.25 | 0.000205 | 0.000613 |
| GO:2000845 | positive regulation of testosterone secretion | 50.0% (1/2) | 12.25 | 0.000205 | 0.000613 |
| GO:0031401 | positive regulation of protein modification process | 100.0% (2/2) | 6.06 | 0.000224 | 0.000665 |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 100.0% (2/2) | 6.02 | 0.000238 | 0.000701 |
| GO:0019904 | protein domain specific binding | 100.0% (2/2) | 5.98 | 0.000251 | 0.000736 |
| GO:1903046 | meiotic cell cycle process | 100.0% (2/2) | 5.93 | 0.000269 | 0.000784 |
| GO:0030001 | metal ion transport | 100.0% (2/2) | 5.87 | 0.000293 | 0.000846 |
| GO:0051301 | cell division | 100.0% (2/2) | 5.86 | 0.000298 | 0.000855 |
| GO:0001935 | endothelial cell proliferation | 50.0% (1/2) | 11.67 | 0.000307 | 0.000876 |
| GO:1903047 | mitotic cell cycle process | 100.0% (2/2) | 5.74 | 0.000347 | 0.000985 |
| GO:0042981 | regulation of apoptotic process | 100.0% (2/2) | 5.73 | 0.000352 | 0.000992 |
| GO:0050778 | positive regulation of immune response | 100.0% (2/2) | 5.7 | 0.000368 | 0.001029 |
| GO:0044087 | regulation of cellular component biogenesis | 100.0% (2/2) | 5.68 | 0.000383 | 0.001063 |
| GO:0010200 | response to chitin | 100.0% (2/2) | 5.55 | 0.000455 | 0.001256 |
| GO:0071367 | cellular response to brassinosteroid stimulus | 50.0% (1/2) | 11.08 | 0.00046 | 0.001263 |
| GO:0002684 | positive regulation of immune system process | 100.0% (2/2) | 5.51 | 0.000478 | 0.001303 |
| GO:0022412 | cellular process involved in reproduction in multicellular organism | 100.0% (2/2) | 5.48 | 0.000498 | 0.00135 |
| GO:2000489 | regulation of hepatic stellate cell activation | 50.0% (1/2) | 10.93 | 0.000512 | 0.001369 |
| GO:2000491 | positive regulation of hepatic stellate cell activation | 50.0% (1/2) | 10.93 | 0.000512 | 0.001369 |
| GO:1901657 | glycosyl compound metabolic process | 100.0% (2/2) | 5.45 | 0.000526 | 0.001398 |
| GO:0006812 | cation transport | 100.0% (2/2) | 5.42 | 0.000541 | 0.00143 |
| GO:0045595 | regulation of cell differentiation | 100.0% (2/2) | 5.42 | 0.000547 | 0.001437 |
| GO:0010712 | regulation of collagen metabolic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.001442 |
| GO:0010714 | positive regulation of collagen metabolic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.001442 |
| GO:0032965 | regulation of collagen biosynthetic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.001442 |
| GO:0032967 | positive regulation of collagen biosynthetic process | 50.0% (1/2) | 10.8 | 0.000563 | 0.001442 |
| GO:0042127 | regulation of cell population proliferation | 100.0% (2/2) | 5.38 | 0.000574 | 0.001462 |
| GO:0050673 | epithelial cell proliferation | 50.0% (1/2) | 10.67 | 0.000614 | 0.001537 |
| GO:0060252 | positive regulation of glial cell proliferation | 50.0% (1/2) | 10.67 | 0.000614 | 0.001537 |
| GO:1904961 | quiescent center organization | 50.0% (1/2) | 10.67 | 0.000614 | 0.001537 |
| GO:0051240 | positive regulation of multicellular organismal process | 100.0% (2/2) | 5.19 | 0.000751 | 0.001827 |
| GO:0009967 | positive regulation of signal transduction | 100.0% (2/2) | 5.19 | 0.000747 | 0.001828 |
| GO:0048609 | multicellular organismal reproductive process | 100.0% (2/2) | 5.19 | 0.000747 | 0.001828 |
| GO:0051247 | positive regulation of protein metabolic process | 100.0% (2/2) | 5.2 | 0.000735 | 0.001828 |
| GO:0034660 | ncRNA metabolic process | 100.0% (2/2) | 5.2 | 0.00074 | 0.001831 |
| GO:0048513 | animal organ development | 100.0% (2/2) | 5.14 | 0.000801 | 0.001927 |
| GO:0043067 | regulation of programmed cell death | 100.0% (2/2) | 5.15 | 0.000797 | 0.001927 |
| GO:0031399 | regulation of protein modification process | 100.0% (2/2) | 5.13 | 0.00081 | 0.001937 |
| GO:0060251 | regulation of glial cell proliferation | 50.0% (1/2) | 10.25 | 0.000819 | 0.001946 |
| GO:0006790 | sulfur compound metabolic process | 100.0% (2/2) | 5.1 | 0.000847 | 0.002003 |
| GO:0023056 | positive regulation of signaling | 100.0% (2/2) | 5.08 | 0.000872 | 0.00204 |
| GO:0051093 | negative regulation of developmental process | 100.0% (2/2) | 5.08 | 0.000869 | 0.002044 |
| GO:0010647 | positive regulation of cell communication | 100.0% (2/2) | 5.06 | 0.000894 | 0.002068 |
| GO:0048364 | root development | 100.0% (2/2) | 5.07 | 0.000889 | 0.002068 |
| GO:0045892 | negative regulation of DNA-templated transcription | 100.0% (2/2) | 4.94 | 0.001065 | 0.00245 |
| GO:1902679 | negative regulation of RNA biosynthetic process | 100.0% (2/2) | 4.93 | 0.001082 | 0.002462 |
| GO:1903507 | negative regulation of nucleic acid-templated transcription | 100.0% (2/2) | 4.93 | 0.001082 | 0.002462 |
| GO:0010941 | regulation of cell death | 100.0% (2/2) | 4.89 | 0.001131 | 0.002534 |
| GO:0048146 | positive regulation of fibroblast proliferation | 50.0% (1/2) | 9.8 | 0.001125 | 0.002535 |
| GO:0071300 | cellular response to retinoic acid | 50.0% (1/2) | 9.8 | 0.001125 | 0.002535 |
| GO:0051094 | positive regulation of developmental process | 100.0% (2/2) | 4.81 | 0.001264 | 0.002817 |
| GO:0006357 | regulation of transcription by RNA polymerase II | 100.0% (2/2) | 4.79 | 0.001298 | 0.00288 |
| GO:0051253 | negative regulation of RNA metabolic process | 100.0% (2/2) | 4.77 | 0.001341 | 0.002959 |
| GO:0050776 | regulation of immune response | 100.0% (2/2) | 4.76 | 0.001353 | 0.002969 |
| GO:0014015 | positive regulation of gliogenesis | 50.0% (1/2) | 9.5 | 0.001381 | 0.003016 |
| GO:0009790 | embryo development | 100.0% (2/2) | 4.73 | 0.001419 | 0.003083 |
| GO:0022402 | cell cycle process | 100.0% (2/2) | 4.71 | 0.001464 | 0.003133 |
| GO:0006811 | ion transport | 100.0% (2/2) | 4.71 | 0.001458 | 0.003136 |
| GO:0048646 | anatomical structure formation involved in morphogenesis | 100.0% (2/2) | 4.71 | 0.001452 | 0.003139 |
| GO:0031523 | Myb complex | 50.0% (1/2) | 9.3 | 0.001586 | 0.003376 |
| GO:0010558 | negative regulation of macromolecule biosynthetic process | 100.0% (2/2) | 4.64 | 0.001602 | 0.003394 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.64 | 0.001614 | 0.003404 |
| GO:0071310 | cellular response to organic substance | 100.0% (2/2) | 4.62 | 0.001647 | 0.003456 |
| GO:0048145 | regulation of fibroblast proliferation | 50.0% (1/2) | 9.17 | 0.001739 | 0.003631 |
| GO:0002831 | regulation of response to biotic stimulus | 100.0% (2/2) | 4.55 | 0.001833 | 0.003772 |
| GO:0002682 | regulation of immune system process | 100.0% (2/2) | 4.55 | 0.001826 | 0.003777 |
| GO:0031327 | negative regulation of cellular biosynthetic process | 100.0% (2/2) | 4.55 | 0.001824 | 0.00379 |
| GO:0042742 | defense response to bacterium | 100.0% (2/2) | 4.53 | 0.001875 | 0.003821 |
| GO:0010243 | response to organonitrogen compound | 100.0% (2/2) | 4.53 | 0.00187 | 0.00383 |
| GO:0032526 | response to retinoic acid | 50.0% (1/2) | 9.04 | 0.001892 | 0.003838 |
| GO:0009890 | negative regulation of biosynthetic process | 100.0% (2/2) | 4.51 | 0.001917 | 0.003871 |
| GO:0003700 | DNA-binding transcription factor activity | 100.0% (2/2) | 4.49 | 0.001985 | 0.003989 |
| GO:0014013 | regulation of gliogenesis | 50.0% (1/2) | 8.97 | 0.001995 | 0.003989 |
| GO:0005654 | nucleoplasm | 100.0% (2/2) | 4.45 | 0.002084 | 0.004111 |
| GO:0009414 | response to water deprivation | 100.0% (2/2) | 4.46 | 0.002077 | 0.004116 |
| GO:1901135 | carbohydrate derivative metabolic process | 100.0% (2/2) | 4.46 | 0.002073 | 0.004126 |
| GO:0002376 | immune system process | 100.0% (2/2) | 4.43 | 0.002143 | 0.004208 |
| GO:1902680 | positive regulation of RNA biosynthetic process | 100.0% (2/2) | 4.39 | 0.00227 | 0.004338 |
| GO:0009415 | response to water | 100.0% (2/2) | 4.4 | 0.002253 | 0.004344 |
| GO:0045893 | positive regulation of DNA-templated transcription | 100.0% (2/2) | 4.41 | 0.002224 | 0.004347 |
| GO:1903508 | positive regulation of nucleic acid-templated transcription | 100.0% (2/2) | 4.39 | 0.002266 | 0.004348 |
| GO:0030154 | cell differentiation | 100.0% (2/2) | 4.4 | 0.002251 | 0.004359 |
| GO:0048661 | positive regulation of smooth muscle cell proliferation | 50.0% (1/2) | 8.8 | 0.00225 | 0.004377 |
| GO:0019748 | secondary metabolic process | 100.0% (2/2) | 4.36 | 0.002362 | 0.004472 |
| GO:0048660 | regulation of smooth muscle cell proliferation | 50.0% (1/2) | 8.73 | 0.002352 | 0.004475 |
| GO:1901698 | response to nitrogen compound | 100.0% (2/2) | 4.36 | 0.002382 | 0.00449 |
| GO:0032101 | regulation of response to external stimulus | 100.0% (2/2) | 4.35 | 0.002409 | 0.004503 |
| GO:0046887 | positive regulation of hormone secretion | 50.0% (1/2) | 8.7 | 0.002403 | 0.004512 |
| GO:0000976 | transcription cis-regulatory region binding | 100.0% (2/2) | 4.34 | 0.002452 | 0.004563 |
| GO:0001067 | transcription regulatory region nucleic acid binding | 100.0% (2/2) | 4.33 | 0.00247 | 0.004576 |
| GO:0001101 | response to acid chemical | 100.0% (2/2) | 4.31 | 0.002531 | 0.004669 |
| GO:1990837 | sequence-specific double-stranded DNA binding | 100.0% (2/2) | 4.3 | 0.002567 | 0.004716 |
| GO:0031347 | regulation of defense response | 100.0% (2/2) | 4.28 | 0.002664 | 0.004852 |
| GO:0032370 | positive regulation of lipid transport | 50.0% (1/2) | 8.55 | 0.002659 | 0.004863 |
| GO:0051254 | positive regulation of RNA metabolic process | 100.0% (2/2) | 4.24 | 0.002784 | 0.005049 |
| GO:0099402 | plant organ development | 100.0% (2/2) | 4.22 | 0.00286 | 0.005166 |
| GO:0140110 | transcription regulator activity | 100.0% (2/2) | 4.21 | 0.002929 | 0.005268 |
| GO:0009791 | post-embryonic development | 100.0% (2/2) | 4.2 | 0.002949 | 0.00528 |
| GO:0042592 | homeostatic process | 100.0% (2/2) | 4.19 | 0.002996 | 0.005343 |
| GO:0051246 | regulation of protein metabolic process | 100.0% (2/2) | 4.17 | 0.003072 | 0.005345 |
| GO:2000026 | regulation of multicellular organismal development | 100.0% (2/2) | 4.18 | 0.003027 | 0.005353 |
| GO:0080060 | integument development | 50.0% (1/2) | 8.35 | 0.003068 | 0.005359 |
| GO:1905954 | positive regulation of lipid localization | 50.0% (1/2) | 8.35 | 0.003068 | 0.005359 |
| GO:0003690 | double-stranded DNA binding | 100.0% (2/2) | 4.19 | 0.003018 | 0.005361 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 100.0% (2/2) | 4.18 | 0.003058 | 0.005386 |
| GO:0051782 | negative regulation of cell division | 50.0% (1/2) | 8.28 | 0.003221 | 0.005581 |
| GO:0048585 | negative regulation of response to stimulus | 100.0% (2/2) | 4.14 | 0.003236 | 0.005585 |
| GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.13 | 0.003259 | 0.005602 |
| GO:0016070 | RNA metabolic process | 100.0% (2/2) | 4.07 | 0.003561 | 0.006072 |
| GO:0031324 | negative regulation of cellular metabolic process | 100.0% (2/2) | 4.07 | 0.003549 | 0.006075 |
| GO:0043565 | sequence-specific DNA binding | 100.0% (2/2) | 4.06 | 0.003616 | 0.006142 |
| GO:0051172 | negative regulation of nitrogen compound metabolic process | 100.0% (2/2) | 4.05 | 0.003662 | 0.006196 |
| GO:0046883 | regulation of hormone secretion | 50.0% (1/2) | 8.04 | 0.003783 | 0.006374 |
| GO:0032368 | regulation of lipid transport | 50.0% (1/2) | 8.01 | 0.003885 | 0.006521 |
| GO:0031328 | positive regulation of cellular biosynthetic process | 100.0% (2/2) | 4.0 | 0.003911 | 0.006539 |
| GO:0009617 | response to bacterium | 100.0% (2/2) | 3.99 | 0.003963 | 0.006599 |
| GO:0009891 | positive regulation of biosynthetic process | 100.0% (2/2) | 3.97 | 0.00405 | 0.006719 |
| GO:0048584 | positive regulation of response to stimulus | 100.0% (2/2) | 3.94 | 0.004214 | 0.006964 |
| GO:0090307 | mitotic spindle assembly | 50.0% (1/2) | 7.83 | 0.004396 | 0.007236 |
| GO:0007275 | multicellular organism development | 100.0% (2/2) | 3.89 | 0.004553 | 0.007466 |
| GO:0043436 | oxoacid metabolic process | 100.0% (2/2) | 3.88 | 0.004612 | 0.007534 |
| GO:0070301 | cellular response to hydrogen peroxide | 50.0% (1/2) | 7.64 | 0.005008 | 0.00815 |
| GO:0006082 | organic acid metabolic process | 100.0% (2/2) | 3.8 | 0.005159 | 0.008364 |
| GO:0009966 | regulation of signal transduction | 100.0% (2/2) | 3.79 | 0.005225 | 0.008439 |
| GO:0080113 | regulation of seed growth | 50.0% (1/2) | 7.57 | 0.005263 | 0.008469 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 100.0% (2/2) | 3.78 | 0.005292 | 0.008483 |
| GO:1905952 | regulation of lipid localization | 50.0% (1/2) | 7.54 | 0.005365 | 0.008569 |
| GO:0048869 | cellular developmental process | 100.0% (2/2) | 3.74 | 0.005575 | 0.00887 |
| GO:0070887 | cellular response to chemical stimulus | 100.0% (2/2) | 3.73 | 0.005652 | 0.008959 |
| GO:0042802 | identical protein binding | 100.0% (2/2) | 3.7 | 0.005928 | 0.009362 |
| GO:0023051 | regulation of signaling | 100.0% (2/2) | 3.68 | 0.006055 | 0.009458 |
| GO:0006996 | organelle organization | 100.0% (2/2) | 3.68 | 0.006079 | 0.009461 |
| GO:0001819 | positive regulation of cytokine production | 50.0% (1/2) | 7.37 | 0.006029 | 0.009486 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 100.0% (2/2) | 3.68 | 0.006051 | 0.009486 |
| GO:0010646 | regulation of cell communication | 100.0% (2/2) | 3.67 | 0.006143 | 0.009526 |
| GO:0048579 | negative regulation of long-day photoperiodism, flowering | 50.0% (1/2) | 7.32 | 0.006233 | 0.00963 |
| GO:0050769 | positive regulation of neurogenesis | 50.0% (1/2) | 7.3 | 0.006335 | 0.009718 |
| GO:0080134 | regulation of response to stress | 100.0% (2/2) | 3.65 | 0.006316 | 0.009724 |
| GO:0051239 | regulation of multicellular organismal process | 100.0% (2/2) | 3.64 | 0.006451 | 0.009826 |
| GO:0007052 | mitotic spindle organization | 50.0% (1/2) | 7.28 | 0.006437 | 0.009839 |
| GO:0009892 | negative regulation of metabolic process | 100.0% (2/2) | 3.63 | 0.006492 | 0.009854 |
| GO:1903532 | positive regulation of secretion by cell | 50.0% (1/2) | 7.25 | 0.006539 | 0.009889 |
| GO:0051047 | positive regulation of secretion | 50.0% (1/2) | 7.23 | 0.006641 | 0.010008 |
| GO:0090304 | nucleic acid metabolic process | 100.0% (2/2) | 3.6 | 0.006801 | 0.010214 |
| GO:0031325 | positive regulation of cellular metabolic process | 100.0% (2/2) | 3.59 | 0.006856 | 0.01026 |
| GO:0034614 | cellular response to reactive oxygen species | 50.0% (1/2) | 7.17 | 0.006947 | 0.010359 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 100.0% (2/2) | 3.58 | 0.007009 | 0.010417 |
| GO:0048532 | anatomical structure arrangement | 50.0% (1/2) | 7.15 | 0.007049 | 0.010439 |
| GO:0051962 | positive regulation of nervous system development | 50.0% (1/2) | 7.14 | 0.0071 | 0.010478 |
| GO:0003677 | DNA binding | 100.0% (2/2) | 3.57 | 0.00713 | 0.010487 |
| GO:0051225 | spindle assembly | 50.0% (1/2) | 7.02 | 0.007711 | 0.011303 |
| GO:0033993 | response to lipid | 100.0% (2/2) | 3.5 | 0.007806 | 0.011403 |
| GO:0006355 | regulation of DNA-templated transcription | 100.0% (2/2) | 3.47 | 0.008098 | 0.011789 |
| GO:2001141 | regulation of RNA biosynthetic process | 100.0% (2/2) | 3.47 | 0.008154 | 0.01179 |
| GO:1903506 | regulation of nucleic acid-templated transcription | 100.0% (2/2) | 3.47 | 0.008144 | 0.011816 |
| GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 50.0% (1/2) | 6.9 | 0.008374 | 0.012067 |
| GO:0010720 | positive regulation of cell development | 50.0% (1/2) | 6.75 | 0.009291 | 0.013299 |
| GO:0009893 | positive regulation of metabolic process | 100.0% (2/2) | 3.37 | 0.00929 | 0.013343 |
| GO:0001817 | regulation of cytokine production | 50.0% (1/2) | 6.72 | 0.009444 | 0.013473 |
| GO:0050767 | regulation of neurogenesis | 50.0% (1/2) | 6.71 | 0.009545 | 0.013573 |
| GO:0044281 | small molecule metabolic process | 100.0% (2/2) | 3.35 | 0.009589 | 0.013589 |
| GO:0010035 | response to inorganic substance | 100.0% (2/2) | 3.35 | 0.009659 | 0.013644 |
| GO:0051252 | regulation of RNA metabolic process | 100.0% (2/2) | 3.34 | 0.009805 | 0.013805 |
| GO:0008283 | cell population proliferation | 50.0% (1/2) | 6.64 | 0.010004 | 0.014038 |
| GO:0006139 | nucleobase-containing compound metabolic process | 100.0% (2/2) | 3.31 | 0.010194 | 0.014258 |
| GO:0048586 | regulation of long-day photoperiodism, flowering | 50.0% (1/2) | 6.56 | 0.010564 | 0.014727 |
| GO:0051960 | regulation of nervous system development | 50.0% (1/2) | 6.49 | 0.011123 | 0.015407 |
| GO:0007051 | spindle organization | 50.0% (1/2) | 6.49 | 0.011123 | 0.015407 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 100.0% (2/2) | 3.23 | 0.011368 | 0.015695 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 3.22 | 0.011593 | 0.015954 |
| GO:1903530 | regulation of secretion by cell | 50.0% (1/2) | 6.4 | 0.011836 | 0.016236 |
| GO:0034599 | cellular response to oxidative stress | 50.0% (1/2) | 6.38 | 0.011988 | 0.016393 |
| GO:0050793 | regulation of developmental process | 100.0% (2/2) | 3.18 | 0.012229 | 0.016669 |
| GO:0006810 | transport | 100.0% (2/2) | 3.17 | 0.012308 | 0.016724 |
| GO:0098542 | defense response to other organism | 100.0% (2/2) | 3.17 | 0.012399 | 0.016794 |
| GO:0048523 | negative regulation of cellular process | 100.0% (2/2) | 3.16 | 0.012542 | 0.016934 |
| GO:0009725 | response to hormone | 100.0% (2/2) | 3.16 | 0.0126 | 0.016958 |
| GO:0051046 | regulation of secretion | 50.0% (1/2) | 6.28 | 0.012853 | 0.017244 |
| GO:0065008 | regulation of biological quality | 100.0% (2/2) | 3.11 | 0.013322 | 0.017818 |
| GO:0051234 | establishment of localization | 100.0% (2/2) | 3.11 | 0.013446 | 0.017928 |
| GO:0060284 | regulation of cell development | 50.0% (1/2) | 6.14 | 0.014174 | 0.01884 |
| GO:0009719 | response to endogenous stimulus | 100.0% (2/2) | 3.06 | 0.014412 | 0.019097 |
| GO:0031326 | regulation of cellular biosynthetic process | 100.0% (2/2) | 3.01 | 0.015348 | 0.020275 |
| GO:0010468 | regulation of gene expression | 100.0% (2/2) | 2.96 | 0.016399 | 0.02153 |
| GO:0009889 | regulation of biosynthetic process | 100.0% (2/2) | 2.97 | 0.016366 | 0.021553 |
| GO:0046483 | heterocycle metabolic process | 100.0% (2/2) | 2.92 | 0.017336 | 0.022691 |
| GO:0140694 | non-membrane-bounded organelle assembly | 50.0% (1/2) | 5.82 | 0.017676 | 0.023065 |
| GO:0051179 | localization | 100.0% (2/2) | 2.9 | 0.017845 | 0.023215 |
| GO:0071407 | cellular response to organic cyclic compound | 50.0% (1/2) | 5.79 | 0.01798 | 0.02332 |
| GO:0006952 | defense response | 100.0% (2/2) | 2.89 | 0.018237 | 0.023581 |
| GO:2000028 | regulation of photoperiodism, flowering | 50.0% (1/2) | 5.76 | 0.018386 | 0.023631 |
| GO:0048583 | regulation of response to stimulus | 100.0% (2/2) | 2.88 | 0.018347 | 0.023653 |
| GO:0034641 | cellular nitrogen compound metabolic process | 100.0% (2/2) | 2.87 | 0.018591 | 0.023823 |
| GO:0048522 | positive regulation of cellular process | 100.0% (2/2) | 2.85 | 0.019139 | 0.024452 |
| GO:2000242 | negative regulation of reproductive process | 50.0% (1/2) | 5.64 | 0.020008 | 0.025486 |
| GO:0003006 | developmental process involved in reproduction | 100.0% (2/2) | 2.81 | 0.020201 | 0.025656 |
| GO:0005829 | cytosol | 100.0% (2/2) | 2.81 | 0.020325 | 0.025737 |
| GO:0051302 | regulation of cell division | 50.0% (1/2) | 5.6 | 0.020514 | 0.0259 |
| GO:0009741 | response to brassinosteroid | 50.0% (1/2) | 5.59 | 0.020666 | 0.025939 |
| GO:0042542 | response to hydrogen peroxide | 50.0% (1/2) | 5.59 | 0.020615 | 0.025951 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 100.0% (2/2) | 2.78 | 0.02118 | 0.026428 |
| GO:0003676 | nucleic acid binding | 100.0% (2/2) | 2.78 | 0.021157 | 0.026478 |
| GO:0071396 | cellular response to lipid | 50.0% (1/2) | 5.53 | 0.021577 | 0.026846 |
| GO:0051716 | cellular response to stimulus | 100.0% (2/2) | 2.76 | 0.021689 | 0.026907 |
| GO:0009738 | abscisic acid-activated signaling pathway | 50.0% (1/2) | 5.51 | 0.021881 | 0.027067 |
| GO:0051707 | response to other organism | 100.0% (2/2) | 2.74 | 0.02238 | 0.027604 |
| GO:0006725 | cellular aromatic compound metabolic process | 100.0% (2/2) | 2.73 | 0.022757 | 0.027988 |
| GO:0048519 | negative regulation of biological process | 100.0% (2/2) | 2.7 | 0.023543 | 0.028872 |
| GO:0044419 | biological process involved in interspecies interaction between organisms | 100.0% (2/2) | 2.7 | 0.023693 | 0.028973 |
| GO:0080090 | regulation of primary metabolic process | 100.0% (2/2) | 2.69 | 0.024112 | 0.029401 |
| GO:0060255 | regulation of macromolecule metabolic process | 100.0% (2/2) | 2.66 | 0.024978 | 0.03037 |
| GO:0062197 | cellular response to chemical stress | 50.0% (1/2) | 5.29 | 0.025471 | 0.030882 |
| GO:0043207 | response to external biotic stimulus | 100.0% (2/2) | 2.64 | 0.025686 | 0.031055 |
| GO:0016043 | cellular component organization | 100.0% (2/2) | 2.61 | 0.026671 | 0.031886 |
| GO:1901700 | response to oxygen-containing compound | 100.0% (2/2) | 2.61 | 0.026671 | 0.031886 |
| GO:0031323 | regulation of cellular metabolic process | 100.0% (2/2) | 2.62 | 0.026604 | 0.031985 |
| GO:0009607 | response to biotic stimulus | 100.0% (2/2) | 2.62 | 0.026563 | 0.032025 |
| GO:0070925 | organelle assembly | 50.0% (1/2) | 5.19 | 0.027187 | 0.032413 |
| GO:1901360 | organic cyclic compound metabolic process | 100.0% (2/2) | 2.6 | 0.027268 | 0.032418 |
| GO:0000226 | microtubule cytoskeleton organization | 50.0% (1/2) | 5.1 | 0.029003 | 0.034386 |
| GO:0051050 | positive regulation of transport | 50.0% (1/2) | 5.09 | 0.029104 | 0.03441 |
| GO:0001666 | response to hypoxia | 50.0% (1/2) | 5.05 | 0.029961 | 0.035132 |
| GO:0032870 | cellular response to hormone stimulus | 50.0% (1/2) | 5.05 | 0.029961 | 0.035132 |
| GO:0048518 | positive regulation of biological process | 100.0% (2/2) | 2.53 | 0.029835 | 0.035177 |
| GO:0048581 | negative regulation of post-embryonic development | 50.0% (1/2) | 5.04 | 0.030112 | 0.035213 |
| GO:0071840 | cellular component organization or biogenesis | 100.0% (2/2) | 2.52 | 0.030234 | 0.035259 |
| GO:0022414 | reproductive process | 100.0% (2/2) | 2.51 | 0.030977 | 0.036027 |
| GO:0036293 | response to decreased oxygen levels | 50.0% (1/2) | 4.96 | 0.031825 | 0.036913 |
| GO:0032501 | multicellular organismal process | 100.0% (2/2) | 2.47 | 0.032398 | 0.037476 |
| GO:0010033 | response to organic substance | 100.0% (2/2) | 2.46 | 0.033055 | 0.038133 |
| GO:0070482 | response to oxygen levels | 50.0% (1/2) | 4.88 | 0.033586 | 0.038642 |
| GO:0009628 | response to abiotic stimulus | 100.0% (2/2) | 2.38 | 0.036714 | 0.042127 |
| GO:0019222 | regulation of metabolic process | 100.0% (2/2) | 2.38 | 0.036999 | 0.042341 |
| GO:0048856 | anatomical structure development | 100.0% (2/2) | 2.33 | 0.039796 | 0.04506 |
| GO:0007017 | microtubule-based process | 50.0% (1/2) | 4.64 | 0.039713 | 0.045085 |
| GO:0000302 | response to reactive oxygen species | 50.0% (1/2) | 4.65 | 0.039562 | 0.045154 |
| GO:0009605 | response to external stimulus | 100.0% (2/2) | 2.33 | 0.039704 | 0.045195 |
| GO:0009555 | pollen development | 50.0% (1/2) | 4.61 | 0.040515 | 0.045753 |
| GO:0007010 | cytoskeleton organization | 50.0% (1/2) | 4.54 | 0.042569 | 0.047946 |